Marc Cluzel
Chairman bei MORPHOSYS AG
Vermögen: 618 710 $ am 31.03.2024
Aktive Positionen von Marc Cluzel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MORPHOSYS AG | Independent Dir/Board Member | 31.05.2012 | - |
Chairman | 17.05.2018 | - | |
Director/Board Member | 31.05.2012 | 17.05.2018 | |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - | |
Griffon Pharmaceuticals, Inc.
Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada. | Director/Board Member | - | - |
Karriereverlauf von Marc Cluzel
Ehemalige bekannte Positionen von Marc Cluzel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2011 | 02.01.2012 |
Sanofi-Aventis Recherche et Développement SA
Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The private company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Chief Executive Officer | 01.01.2002 | 01.01.2011 |
Chairman | 01.01.2002 | 01.01.2011 | |
SANOFI | Chief Tech/Sci/R&D Officer | 01.01.2007 | 01.01.2010 |
General Counsel | 01.01.2007 | 01.01.2009 | |
Corporate Officer/Principal | 01.01.1991 | 01.01.2007 | |
C&F Consulting | Founder | 01.01.2011 | - |
Ausbildung von Marc Cluzel
Université de Montpellier | Doctorate Degree |
Statistik
International
Frankreich | 5 |
Singapur | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chairman | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SANOFI | Commercial Services |
MORPHOSYS AG | Health Technology |
Private Unternehmen | 5 |
---|---|
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Health Technology |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Sanofi-Aventis Recherche et Développement SA
Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The private company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Commercial Services |
C&F Consulting | |
Griffon Pharmaceuticals, Inc.
Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada. | Health Technology |
- Börse
- Insiders
- Marc Cluzel
- Erfahrung